 | • レポートコード：MRC2-11QY11434 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は大腸がん診断・治療のグローバル市場について調査・分析したレポートです。種類別（診断、治療）市場規模、用途別（病院、診断センター、研究機関）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別大腸がん診断・治療の競争状況、市場シェア ・世界の大腸がん診断・治療市場：種類別市場規模 2015年-2020年（診断、治療） ・世界の大腸がん診断・治療市場：種類別市場規模予測 2021年-2026年（診断、治療） ・世界の大腸がん診断・治療市場：用途別市場規模 2015年-2020年（病院、診断センター、研究機関） ・世界の大腸がん診断・治療市場：用途別市場規模予測 2021年-2026年（病院、診断センター、研究機関） ・北米の大腸がん診断・治療市場分析：米国、カナダ ・ヨーロッパの大腸がん診断・治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの大腸がん診断・治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の大腸がん診断・治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの大腸がん診断・治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Abbott、Beckman Coulter、Clinical Genomics、Volition RX、EDP Biotech、Epigenomics、Novigenix、Siemens、Quest Diagnostics、Metabiomics ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Colorectal cancer is the development of cancer from the colonor rectum.
The main market drivers are increasing cancer prevention initiatives, technological advancements in radiology and chemotherapy, and increasing incidence and prevalence of colorectal cancer.
Market Analysis and Insights: Global Colorectal Cancer Diagnosis and Therapeutics Market
The global Colorectal Cancer Diagnosis and Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Colorectal Cancer Diagnosis and Therapeutics Scope and Market Size
Colorectal Cancer Diagnosis and Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Colorectal Cancer Diagnosis and Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Abbott
Beckman Coulter
Clinical Genomics
Volition RX
EDP Biotech
Epigenomics
Novigenix
Siemens
Quest Diagnostics
Metabiomics
Market segment by Type, the product can be split into
Diagnostics
Therapeutics
Market segment by Application, split into
Hospitals
Diagnostic centres
Research institutions
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Colorectal Cancer Diagnosis and Therapeutics Revenue
1.4 Market by Type
1.4.1 Global Colorectal Cancer Diagnosis and Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Diagnostics
1.4.3 Therapeutics
1.5 Market by Application
1.5.1 Global Colorectal Cancer Diagnosis and Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Diagnostic centres
1.5.4 Research institutions
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Colorectal Cancer Diagnosis and Therapeutics Market Perspective (2015-2026)
2.2 Global Colorectal Cancer Diagnosis and Therapeutics Growth Trends by Regions
2.2.1 Colorectal Cancer Diagnosis and Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Colorectal Cancer Diagnosis and Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Colorectal Cancer Diagnosis and Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Colorectal Cancer Diagnosis and Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Colorectal Cancer Diagnosis and Therapeutics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Colorectal Cancer Diagnosis and Therapeutics Players by Market Size
3.1.1 Global Top Colorectal Cancer Diagnosis and Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Colorectal Cancer Diagnosis and Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Colorectal Cancer Diagnosis and Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Colorectal Cancer Diagnosis and Therapeutics Market Concentration Ratio
3.2.1 Global Colorectal Cancer Diagnosis and Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Colorectal Cancer Diagnosis and Therapeutics Revenue in 2019
3.3 Colorectal Cancer Diagnosis and Therapeutics Key Players Head office and Area Served
3.4 Key Players Colorectal Cancer Diagnosis and Therapeutics Product Solution and Service
3.5 Date of Enter into Colorectal Cancer Diagnosis and Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Colorectal Cancer Diagnosis and Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Colorectal Cancer Diagnosis and Therapeutics Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Colorectal Cancer Diagnosis and Therapeutics Market Size by Application (2015-2020)
5.2 Global Colorectal Cancer Diagnosis and Therapeutics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Colorectal Cancer Diagnosis and Therapeutics Market Size (2015-2020)
6.2 Colorectal Cancer Diagnosis and Therapeutics Key Players in North America (2019-2020)
6.3 North America Colorectal Cancer Diagnosis and Therapeutics Market Size by Type (2015-2020)
6.4 North America Colorectal Cancer Diagnosis and Therapeutics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Colorectal Cancer Diagnosis and Therapeutics Market Size (2015-2020)
7.2 Colorectal Cancer Diagnosis and Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Colorectal Cancer Diagnosis and Therapeutics Market Size by Type (2015-2020)
7.4 Europe Colorectal Cancer Diagnosis and Therapeutics Market Size by Application (2015-2020)
8 China
8.1 China Colorectal Cancer Diagnosis and Therapeutics Market Size (2015-2020)
8.2 Colorectal Cancer Diagnosis and Therapeutics Key Players in China (2019-2020)
8.3 China Colorectal Cancer Diagnosis and Therapeutics Market Size by Type (2015-2020)
8.4 China Colorectal Cancer Diagnosis and Therapeutics Market Size by Application (2015-2020)
9 Japan
9.1 Japan Colorectal Cancer Diagnosis and Therapeutics Market Size (2015-2020)
9.2 Colorectal Cancer Diagnosis and Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Colorectal Cancer Diagnosis and Therapeutics Market Size by Type (2015-2020)
9.4 Japan Colorectal Cancer Diagnosis and Therapeutics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Colorectal Cancer Diagnosis and Therapeutics Market Size (2015-2020)
10.2 Colorectal Cancer Diagnosis and Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Colorectal Cancer Diagnosis and Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Colorectal Cancer Diagnosis and Therapeutics Market Size by Application (2015-2020)
11 India
11.1 India Colorectal Cancer Diagnosis and Therapeutics Market Size (2015-2020)
11.2 Colorectal Cancer Diagnosis and Therapeutics Key Players in India (2019-2020)
11.3 India Colorectal Cancer Diagnosis and Therapeutics Market Size by Type (2015-2020)
11.4 India Colorectal Cancer Diagnosis and Therapeutics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Colorectal Cancer Diagnosis and Therapeutics Market Size (2015-2020)
12.2 Colorectal Cancer Diagnosis and Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Colorectal Cancer Diagnosis and Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Colorectal Cancer Diagnosis and Therapeutics Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Abbott
13.1.1 Abbott Company Details
13.1.2 Abbott Business Overview
13.1.3 Abbott Colorectal Cancer Diagnosis and Therapeutics Introduction
13.1.4 Abbott Revenue in Colorectal Cancer Diagnosis and Therapeutics Business (2015-2020))
13.1.5 Abbott Recent Development
13.2 Beckman Coulter
13.2.1 Beckman Coulter Company Details
13.2.2 Beckman Coulter Business Overview
13.2.3 Beckman Coulter Colorectal Cancer Diagnosis and Therapeutics Introduction
13.2.4 Beckman Coulter Revenue in Colorectal Cancer Diagnosis and Therapeutics Business (2015-2020)
13.2.5 Beckman Coulter Recent Development
13.3 Clinical Genomics
13.3.1 Clinical Genomics Company Details
13.3.2 Clinical Genomics Business Overview
13.3.3 Clinical Genomics Colorectal Cancer Diagnosis and Therapeutics Introduction
13.3.4 Clinical Genomics Revenue in Colorectal Cancer Diagnosis and Therapeutics Business (2015-2020)
13.3.5 Clinical Genomics Recent Development
13.4 Volition RX
13.4.1 Volition RX Company Details
13.4.2 Volition RX Business Overview
13.4.3 Volition RX Colorectal Cancer Diagnosis and Therapeutics Introduction
13.4.4 Volition RX Revenue in Colorectal Cancer Diagnosis and Therapeutics Business (2015-2020)
13.4.5 Volition RX Recent Development
13.5 EDP Biotech
13.5.1 EDP Biotech Company Details
13.5.2 EDP Biotech Business Overview
13.5.3 EDP Biotech Colorectal Cancer Diagnosis and Therapeutics Introduction
13.5.4 EDP Biotech Revenue in Colorectal Cancer Diagnosis and Therapeutics Business (2015-2020)
13.5.5 EDP Biotech Recent Development
13.6 Epigenomics
13.6.1 Epigenomics Company Details
13.6.2 Epigenomics Business Overview
13.6.3 Epigenomics Colorectal Cancer Diagnosis and Therapeutics Introduction
13.6.4 Epigenomics Revenue in Colorectal Cancer Diagnosis and Therapeutics Business (2015-2020)
13.6.5 Epigenomics Recent Development
13.7 Novigenix
13.7.1 Novigenix Company Details
13.7.2 Novigenix Business Overview
13.7.3 Novigenix Colorectal Cancer Diagnosis and Therapeutics Introduction
13.7.4 Novigenix Revenue in Colorectal Cancer Diagnosis and Therapeutics Business (2015-2020)
13.7.5 Novigenix Recent Development
13.8 Siemens
13.8.1 Siemens Company Details
13.8.2 Siemens Business Overview
13.8.3 Siemens Colorectal Cancer Diagnosis and Therapeutics Introduction
13.8.4 Siemens Revenue in Colorectal Cancer Diagnosis and Therapeutics Business (2015-2020)
13.8.5 Siemens Recent Development
13.9 Quest Diagnostics
13.9.1 Quest Diagnostics Company Details
13.9.2 Quest Diagnostics Business Overview
13.9.3 Quest Diagnostics Colorectal Cancer Diagnosis and Therapeutics Introduction
13.9.4 Quest Diagnostics Revenue in Colorectal Cancer Diagnosis and Therapeutics Business (2015-2020)
13.9.5 Quest Diagnostics Recent Development
13.10 Metabiomics
13.10.1 Metabiomics Company Details
13.10.2 Metabiomics Business Overview
13.10.3 Metabiomics Colorectal Cancer Diagnosis and Therapeutics Introduction
13.10.4 Metabiomics Revenue in Colorectal Cancer Diagnosis and Therapeutics Business (2015-2020)
13.10.5 Metabiomics Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Colorectal Cancer Diagnosis and Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Colorectal Cancer Diagnosis and Therapeutics Revenue
Table 3. Ranking of Global Top Colorectal Cancer Diagnosis and Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Colorectal Cancer Diagnosis and Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Diagnostics
Table 6. Key Players of Therapeutics
Table 7. Global Colorectal Cancer Diagnosis and Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Colorectal Cancer Diagnosis and Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Colorectal Cancer Diagnosis and Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Colorectal Cancer Diagnosis and Therapeutics Market Share by Regions (2015-2020)
Table 11. Global Colorectal Cancer Diagnosis and Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Colorectal Cancer Diagnosis and Therapeutics Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Colorectal Cancer Diagnosis and Therapeutics Market Growth Strategy
Table 17. Main Points Interviewed from Key Colorectal Cancer Diagnosis and Therapeutics Players
Table 18. Global Colorectal Cancer Diagnosis and Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 19. Global Colorectal Cancer Diagnosis and Therapeutics Market Share by Players (2015-2020)
Table 20. Global Top Colorectal Cancer Diagnosis and Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Colorectal Cancer Diagnosis and Therapeutics as of 2019)
Table 21. Global Colorectal Cancer Diagnosis and Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Colorectal Cancer Diagnosis and Therapeutics Product Solution and Service
Table 24. Date of Enter into Colorectal Cancer Diagnosis and Therapeutics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Colorectal Cancer Diagnosis and Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 27. Global Colorectal Cancer Diagnosis and Therapeutics Market Size Share by Type (2015-2020)
Table 28. Global Colorectal Cancer Diagnosis and Therapeutics Revenue Market Share by Type (2021-2026)
Table 29. Global Colorectal Cancer Diagnosis and Therapeutics Market Size Share by Application (2015-2020)
Table 30. Global Colorectal Cancer Diagnosis and Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 31. Global Colorectal Cancer Diagnosis and Therapeutics Market Size Share by Application (2021-2026)
Table 32. North America Key Players Colorectal Cancer Diagnosis and Therapeutics Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Colorectal Cancer Diagnosis and Therapeutics Market Share (2019-2020)
Table 34. North America Colorectal Cancer Diagnosis and Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 35. North America Colorectal Cancer Diagnosis and Therapeutics Market Share by Type (2015-2020)
Table 36. North America Colorectal Cancer Diagnosis and Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 37. North America Colorectal Cancer Diagnosis and Therapeutics Market Share by Application (2015-2020)
Table 38. Europe Key Players Colorectal Cancer Diagnosis and Therapeutics Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Colorectal Cancer Diagnosis and Therapeutics Market Share (2019-2020)
Table 40. Europe Colorectal Cancer Diagnosis and Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Colorectal Cancer Diagnosis and Therapeutics Market Share by Type (2015-2020)
Table 42. Europe Colorectal Cancer Diagnosis and Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Colorectal Cancer Diagnosis and Therapeutics Market Share by Application (2015-2020)
Table 44. China Key Players Colorectal Cancer Diagnosis and Therapeutics Revenue (2019-2020) (Million US$)
Table 45. China Key Players Colorectal Cancer Diagnosis and Therapeutics Market Share (2019-2020)
Table 46. China Colorectal Cancer Diagnosis and Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 47. China Colorectal Cancer Diagnosis and Therapeutics Market Share by Type (2015-2020)
Table 48. China Colorectal Cancer Diagnosis and Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 49. China Colorectal Cancer Diagnosis and Therapeutics Market Share by Application (2015-2020)
Table 50. Japan Key Players Colorectal Cancer Diagnosis and Therapeutics Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Colorectal Cancer Diagnosis and Therapeutics Market Share (2019-2020)
Table 52. Japan Colorectal Cancer Diagnosis and Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Colorectal Cancer Diagnosis and Therapeutics Market Share by Type (2015-2020)
Table 54. Japan Colorectal Cancer Diagnosis and Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Colorectal Cancer Diagnosis and Therapeutics Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Colorectal Cancer Diagnosis and Therapeutics Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Colorectal Cancer Diagnosis and Therapeutics Market Share (2019-2020)
Table 58. Southeast Asia Colorectal Cancer Diagnosis and Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Colorectal Cancer Diagnosis and Therapeutics Market Share by Type (2015-2020)
Table 60. Southeast Asia Colorectal Cancer Diagnosis and Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Colorectal Cancer Diagnosis and Therapeutics Market Share by Application (2015-2020)
Table 62. India Key Players Colorectal Cancer Diagnosis and Therapeutics Revenue (2019-2020) (Million US$)
Table 63. India Key Players Colorectal Cancer Diagnosis and Therapeutics Market Share (2019-2020)
Table 64. India Colorectal Cancer Diagnosis and Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 65. India Colorectal Cancer Diagnosis and Therapeutics Market Share by Type (2015-2020)
Table 66. India Colorectal Cancer Diagnosis and Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 67. India Colorectal Cancer Diagnosis and Therapeutics Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Colorectal Cancer Diagnosis and Therapeutics Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Colorectal Cancer Diagnosis and Therapeutics Market Share (2019-2020)
Table 70. Central & South America Colorectal Cancer Diagnosis and Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Colorectal Cancer Diagnosis and Therapeutics Market Share by Type (2015-2020)
Table 72. Central & South America Colorectal Cancer Diagnosis and Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Colorectal Cancer Diagnosis and Therapeutics Market Share by Application (2015-2020)
Table 74. Abbott Company Details
Table 75. Abbott Business Overview
Table 76. Abbott Product
Table 77. Abbott Revenue in Colorectal Cancer Diagnosis and Therapeutics Business (2015-2020) (Million US$)
Table 78. Abbott Recent Development
Table 79. Beckman Coulter Company Details
Table 80. Beckman Coulter Business Overview
Table 81. Beckman Coulter Product
Table 82. Beckman Coulter Revenue in Colorectal Cancer Diagnosis and Therapeutics Business (2015-2020) (Million US$)
Table 83. Beckman Coulter Recent Development
Table 84. Clinical Genomics Company Details
Table 85. Clinical Genomics Business Overview
Table 86. Clinical Genomics Product
Table 87. Clinical Genomics Revenue in Colorectal Cancer Diagnosis and Therapeutics Business (2015-2020) (Million US$)
Table 88. Clinical Genomics Recent Development
Table 89. Volition RX Company Details
Table 90. Volition RX Business Overview
Table 91. Volition RX Product
Table 92. Volition RX Revenue in Colorectal Cancer Diagnosis and Therapeutics Business (2015-2020) (Million US$)
Table 93. Volition RX Recent Development
Table 94. EDP Biotech Company Details
Table 95. EDP Biotech Business Overview
Table 96. EDP Biotech Product
Table 97. EDP Biotech Revenue in Colorectal Cancer Diagnosis and Therapeutics Business (2015-2020) (Million US$)
Table 98. EDP Biotech Recent Development
Table 99. Epigenomics Company Details
Table 100. Epigenomics Business Overview
Table 101. Epigenomics Product
Table 102. Epigenomics Revenue in Colorectal Cancer Diagnosis and Therapeutics Business (2015-2020) (Million US$)
Table 103. Epigenomics Recent Development
Table 104. Novigenix Company Details
Table 105. Novigenix Business Overview
Table 106. Novigenix Product
Table 107. Novigenix Revenue in Colorectal Cancer Diagnosis and Therapeutics Business (2015-2020) (Million US$)
Table 108. Novigenix Recent Development
Table 109. Siemens Business Overview
Table 110. Siemens Product
Table 111. Siemens Company Details
Table 112. Siemens Revenue in Colorectal Cancer Diagnosis and Therapeutics Business (2015-2020) (Million US$)
Table 113. Siemens Recent Development
Table 114. Quest Diagnostics Company Details
Table 115. Quest Diagnostics Business Overview
Table 116. Quest Diagnostics Product
Table 117. Quest Diagnostics Revenue in Colorectal Cancer Diagnosis and Therapeutics Business (2015-2020) (Million US$)
Table 118. Quest Diagnostics Recent Development
Table 119. Metabiomics Company Details
Table 120. Metabiomics Business Overview
Table 121. Metabiomics Product
Table 122. Metabiomics Revenue in Colorectal Cancer Diagnosis and Therapeutics Business (2015-2020) (Million US$)
Table 123. Metabiomics Recent Development
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Colorectal Cancer Diagnosis and Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Diagnostics Features
Figure 3. Therapeutics Features
Figure 4. Global Colorectal Cancer Diagnosis and Therapeutics Market Share by Application: 2020 VS 2026
Figure 5. Hospitals Case Studies
Figure 6. Diagnostic centres Case Studies
Figure 7. Research institutions Case Studies
Figure 8. Colorectal Cancer Diagnosis and Therapeutics Report Years Considered
Figure 9. Global Colorectal Cancer Diagnosis and Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Colorectal Cancer Diagnosis and Therapeutics Market Share by Regions: 2020 VS 2026
Figure 11. Global Colorectal Cancer Diagnosis and Therapeutics Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Colorectal Cancer Diagnosis and Therapeutics Market Share by Players in 2019
Figure 14. Global Top Colorectal Cancer Diagnosis and Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Colorectal Cancer Diagnosis and Therapeutics as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Colorectal Cancer Diagnosis and Therapeutics Revenue in 2019
Figure 16. North America Colorectal Cancer Diagnosis and Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Colorectal Cancer Diagnosis and Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Colorectal Cancer Diagnosis and Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Colorectal Cancer Diagnosis and Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Colorectal Cancer Diagnosis and Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Colorectal Cancer Diagnosis and Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Colorectal Cancer Diagnosis and Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Bottom-up and Top-down Approaches for This Report
Figure 24. Data Triangulation
Figure 25. Key Executives Interviewed
骨肉腫診断・治療の世界市場（～2026年） Bone cancer is a malignant tumor that arises from the cells that make up the bones of the body. Robust healthcare expenditure in developed countries, genetic disorder, and development of stem cell transplant technology are some of the major factors that drive the growth of the market. Rising geriatr…- 中咽頭がん診断・治療の世界市場（～2026年） Oropharyngeal cancer is a malignant tumour that starts in the cells of the oropharynx. Rising prevalence of oropharyngeal cancer has been the major factor driving the market growth. Additionally, increasing geriatric population and rising oropharyngeal cancer associated with them is another factor d…
- 肺がん診断・治療の世界市場（～2026年） Lung cancer is a malignant lung tumor characterized by uncontrolled cell growth in tissues of the lung. Robust healthcare expenditure within the developed countries, increasing pollution, government initiatives for lung cancer, and rising cases of smoking are some of the major factors that fuel the …
- 皮膚がん診断・治療の世界市場（～2026年） Skin cancer is the uncontrolled development of anomalous skin cells. The major factor that drives the market is that when the sun rays that is the ultra violet rays comes in contact with skin may cause skin cancer. Market Analysis and Insights: Global Skin Cancer Diagnosis and Therapeutics Market Th…
- 大腸がん診断の世界市場（～2026年） Fecal occult blood tests dominated the industry in 2016 owing to cost effectiveness and non-invasiveness as compared to colonoscopy and sigmoidoscopy. Immuno-FOB agglutination and Immuno-FOB ELISA tests are major revenue generating segments of fecal occult blood tests segment. Growing awareness alon…